Breaking News
Get 45% Off 0
🌊 NVIDIA ripple effect: Track AI stocks' response to chip giant's earnings
Explore AI Stocks

The Zacks Analyst Blog Highlights: Charles Schwab, E*TRADE Financial, TD Ameritrade, Interactive Brokers And Morgan Stanley

By Zacks Investment ResearchStock MarketsMar 20, 2020 07:57AM ET
www.investing.com/analysis/the-zacks-analyst-blog-highlights-charles-schwab-etrade-financial-td-ameritrade-interactive-brokers-and-morgan-stanley-200517645
The Zacks Analyst Blog Highlights: Charles Schwab, E*TRADE Financial, TD Ameritrade, Interactive Brokers And Morgan Stanley
By Zacks Investment Research   |  Mar 20, 2020 07:57AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
 
US500
-1.58%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
DJI
-0.44%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
ETFC
0.00%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
SCHW
-0.34%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
MS
-1.38%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
AMTD
0.00%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

For Immediate Release

Chicago, IL – March 20, 2020 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Charles Schwab (NYSE:SCHW) , E*TRADE Financial (NASDAQ:ETFC) , TD Ameritrade (NASDAQ:AMTD) , Interactive Brokers (NASDAQ:IBKR) and Morgan Stanley (NYSE:MS) .

Here are highlights from Thursday’s Analyst Blog:

Rate Cut to Hurt Online Traders Amid Coronavirus Concerns

The current economic scenario has been affecting companies from all sectors in some way or the other. Fear over the coronavirus (COVID-19) outbreak and its financial impact has made people wary of investing in stock markets.

In fact, markets have become extremely volatile. The S&P 500 Index fell 5.2% yesterday. Further, the Dow Jones Industrial Average declined 6.3% to below the 20,000 level, thus hitting its three-year low.

And, like other industries within the broader Finance sector, online brokerage firms (also known as discount brokerages) will have to bear the brunt of the economic slowdown.

In order to support the economy amid the current crisis, the Federal Reserve on Sunday reduced benchmark interest rates to near zero, after unexpectedly cutting rates by 50 basis points early this month. Because of this, online brokerage firms like Charles Schwab, E*TRADE Financial, TD Ameritrade, Interactive Brokers and others are expected to witness a decline in their interest-related income (which constitutes a significant portion of their revenues) in the coming quarters.

Brokerage firms earn interest income on clients’ brokerage cash. They reinvest brokerage clients’ cash in higher-yielding securities and bag the difference between the interest they receive on securities and the yield they dole out to clients on their cash.

While most brokerage firms have witnessed an increase in net client assets and new brokerage accounts in the past two months, owing to the heightened volatility, their interest-rate related revenues are expected to be hurt to an extent in the coming months as both long and short-term rates have fallen significantly.

Notably, online brokerage firms are already witnessing a decline in commission revenues since announcing commission-free trading in the second half of 2019. Effective October 2019, the major online brokerages started offering commission-free trading to attract new clients. The companies eliminated commissions for stocks, exchange-traded funds (ETFs) and options trades. Nonetheless, they continue to charge 65 cents per contract for options trading. (Read more: Online Brokers' Price War Likely to Affect Revenue Growth)

While garnering market share was the primary reason for announcing zero commission trades, the move has hurt profitability of discount brokers to some extent as they are foregoing substantial fees. In fact, this comes at a time when low interest rates and significant volatility in the markets are already adversely impacting their financials.

However, Schwab seems to be a bit better positioned in terms of reduction in commission from trading as it is less dependent on commissions, which constituted nearly 6% of its total net revenues in 2019. However, the company’s interest income constitutes more than 60% of total revenues, which will likely be affected by the Fed’s latest move.

Notably, in the current scenario, brokerage firms are moving toward consolidation to dodge the heightened costs of regulatory compliance and increased investments in technology to be competitive. Last year, Schwab announced an all-stock deal to acquire TD Ameritrade for $26 billion. The transaction is expected to create a behemoth in the online brokerage space, with combined client assets worth more than $5 trillion. Also, last month, Morgan Stanley entered into an all-stock deal to acquire E*TRADE for $13 billion.

Thus, consolidations of big players within the online brokerage industry are paving the way for the smaller participants to enter the market.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

http://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.



Interactive Brokers Group, Inc. (IBKR): Free Stock Analysis Report

E*TRADE Financial Corporation (ETFC): Free Stock Analysis Report

The Charles Schwab Corporation (SCHW): Free Stock Analysis Report

Morgan Stanley (MS): Free Stock Analysis Report

TD Ameritrade Holding Corporation (AMTD): Free Stock Analysis Report

Original post

Zacks Investment Research

The Zacks Analyst Blog Highlights: Charles Schwab, E*TRADE Financial, TD Ameritrade, Interactive Brokers And Morgan Stanley
 

Related Articles

Timothy Fries
Is Tesla on the Right Track in 2025? By Timothy Fries  - Feb 27, 2025 2

Since the Robotaxi event on October 11th, Tesla (NASDAQ:TSLA) stock is up 38%, currently priced at $291.60 per share This is a return to the early November 2024 price level. But...

The Zacks Analyst Blog Highlights: Charles Schwab, E*TRADE Financial, TD Ameritrade, Interactive Brokers And Morgan Stanley

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email